A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells

Samantha Solito, Erika Falisi, C. Marcela Díaz‐Montero, +10

Blood

Baricitinib restrains the immune dysregulation in patients with severe COVID-19

Vincenzo Bronte, Stefano Ugel, Elisa Tinazzi, +27

Journal of Clinical Investigation

Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3

Rosalinda Trovato, Alessandra Fiore, S Sartori, +21

Journal for ImmunoTherapy of Cancer

The immune suppressive microenvironment of human gliomas depends on the accumulation of bone marrow-derived macrophages in the center of the lesion

Laura Pinton, Elena Masetto, Marina Vettore, +10

Journal for ImmunoTherapy of Cancer

Low dose gemcitabine-loaded lipid nanocapsules target monocytic myeloid-derived suppressor cells and potentiate cancer immunotherapy

Maria Stella Sasso, Giovanna Lollo, Marion Pitorre, +8

Biomaterials

Cell-based Drug DeliveryNanomedicineMedicineImmunologyPharmacology +6

Activated T cells sustain myeloid-derived suppressor cell-mediated immune suppression

Laura Pinton, Samantha Solito, Vera Damuzzo, +7

Oncotarget

Complexity and challenges in defining myeloid-derived suppressor cells

Vera Damuzzo, Laura Pinton, Giacomo Desantis, +4

Cytometry Part B Clinical Cytometry

Hematological MalignancyCancer ImmunosurveillanceMdsc SubsetsMalignant Blood DisorderImmunology +12

Clinical implication of tumor-associated and immunological parameters in melanoma patients treated with ipilimumab

Vera Damuzzo, Samantha Solito, Laura Pinton, +6

OncoImmunology

Immunosuppressive activity of tumor-infiltrating myeloid cells in patients with meningioma

Laura Pinton, Samantha Solito, Elena Masetto, +4

OncoImmunology

Methods to Measure MDSC Immune Suppressive Activity <i>In Vitro</i> and <i>In Vivo</i>

Samantha Solito, Laura Pinton, Francesco De Sanctis, +4

Current Protocols in Immunology